Company intelligence / Profile preview

CellOrigin Technology (Hangzhou) Co., Ltd.

Hangzhou, Zhejiang, Chinaen.cell-origin.com ↗

Ownership: Private
Employees: ~81
Development stage: Preclinical

Overview

CellOrigin has advanced several iPSC-derived innate immune cell therapies into clinical development for cancer indications. Lead assets include SY‑001 for advanced malignant solid neoplasms and iPSC-NK for hematologic cancers, both in the clinical stage. Additional pipeline candidates remain preclinical. The company holds multiple domestic and international patents covering its core technologies

Therapeutic areas: OncologyHematology
Modalities: Induced pluripotent stem cell (iPSC)-derived immune cellsCAR-Macrophages (CAR-M)CAR-NK cellsGene therapyGeneral cell therapy
Industry: Biotech

Partnerships

Qilu Pharma – global strategic collaboration to develop “off-the-shelf” CAR-iMac cell therapy targeting cancer indications

Beyond the preview

Go deeper on CellOrigin Technology (Hangzhou) Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CellOrigin Technology (Hangzhou) Co., Ltd..

Explore the full profile